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Abstract  
 
Objective: In the current study we aimed to evaluate the effect of embryo transfer on gene 
expression during pre-implantation development and its consequences on implantation rate, 
offspring rate at birth and embryonic and fetal losses in the rabbit model.  
Study Design: The mRNA expressions of 8 candidate genes were compared between 6-day-old 
in vivo-produced embryos (non-manipulated embryos) to those of 6-day-old embryos 
previously recovery at the third day of development and transferred into recipient rabbit females 
(manipulated embryos). Furthermore, we compared between both experimental groups the 
implantation rate and offspring rate at birth and embryonic and fetal losses. 
Results: Differences in transcript abundance of OCT4, C1qTNF1, EMP1 and TNFAIP6 were 
observed in transferred embryos. In addition, lower implantation and offspring rates at birth 
were obtained in transferred embryos than in the control group. In addition, embryonic losses 
were significantly higher in the transferred group than in the control. However, fetal losses were 
similar between groups.  
Conclusion: the findings of the current study show that embryo transfer manipulation influenced 
mRNA expression of late blastocysts prior to implantation, resulting in higher gestational losses 
as a consequence of faulty embryonic implantation.  
 







Assisted reproductive technology (ART) has become a routine practice in human medicine to 
overcome fertility problems [1]. ART is currently responsible for 1.7-4% of the births in 
developed countries [2]. Over 5 million ART babies have been delivered worldwide since the 
breakthrough of in vitro fertilization (IVF) technology in 1978, and the demand for ART is 
continually increasing [3]. However, there is increasing concern regarding the safety of ART. In 
animal model experiments, alterations have been observed both throughout gestation and in 
adulthood [1, 3-6]. In human, epidemiologic studies in children conceived by ART showed 
differences in birth weight and the cardiovascular system, as well as a higher risk of imprinting 
disorders [7,8]. The molecular mechanisms that link the in vitro manipulation of gametes and 
embryos with perinatal alterations remain poorly understood. Transfer of embryos into the 
endometrial cavity is a critical step in assisted reproduction and merits the same attention 
reserved for other components of the procedure [9]. 
 
Embryo recovery and transfer is a technique inherent in most ART. Moreover, it is essential to 
study the effects of gamete and embryo manipulations on post-implantation development or in 
adulthood. Historically, the embryo transfer procedure has been of little clinical and scientific 
interest [9]. This technique is regarded as safe and is not considered a manipulation with 
adverse outcomes in normal gene expression [10]. Until now, rather than embryo recovery and 
transfer, most of the studies performed to elucidate the pre- and postnatal consequences of ART 
have focused more on procedures or factors such as media and storage time, intracytoplasmic 
sperm injection, cryopreservation or embryo biopsy that might disturb or affect normal embryo 
development. As a consequence, the specific contribution of recovery and embryo transfer to 
the gene and epigenetic alterations reported in the literature remains poorly understood [4].  
Some studies have found that even the apparently innocuous manipulation of embryo transfer 
itself results in the misexpression of several imprinted genes in the yolk sac and placenta [10]. 
Worse, this effect is more severe and extends to embryonic tissues when mouse embryos are 
cultured in vitro from the two-cell to the blastocyst stage prior to transfer [10]. Recently, it has 
been demonstrated that embryo transfer is not as innocuous as it was previously considered, as 
it induces placentomegaly in mouse fetuses at the end of gestation [4]. Importantly, it was also 
observed that the morphological and epigenetic alterations observed were increasing as more 
ART techniques were applied prior to transfer.  
 
The aim of the present study was to evaluate the effect of embryo transfer on mRNA expression 
of candidate genes during pre-implantation development and link them with implantation and 
offspring rates at birth in the rabbit model. 
 
 
Materials and Methods  
All chemicals, unless otherwise stated, were reagent- grade and purchased from Sigma-Aldrich 
Química S.A. (Alcobendas, Madrid, Spain).  
 
Animals 
New Zealand White rabbits were used. The rabbit has been used as an experimental animal in 
genetics and reproduction physiology since the turn of the century [11]. The great advantage of 
rabbit is that it is one of the few species in which ovulation is induced by mating, resulting in an 
exactly defined pregnancy and embryonic age (hours or days post coitum) [11].  
 
Experimental Design 
The experimental design followed in this study is shown in Fig 1. To assess gene expression 
alterations, a mRNA expression study of 8 candidate genes was performed comparing transcript 
patterns of 6-day-old in vivo-produced embryos (non-manipulated embryos) to those of 6-day-
old embryos previously recovery at the third day of development and transferred into recipient 
rabbit females (manipulated embryos). Furthermore, we compared between both experimental 
groups the implantation rate and offspring rate at birth and embryonic and fetal losses. 
 
 
Embryo production and collection 
Twenty-seven donor does were artificially inseminated with pooled sperm from fertile males. 
Seven does were euthanized at 72 hours post-insemination with an intravenous injection of 200 
mg/Kg of pentobarbital sodium. Embryos were recovered by perfusion of each oviduct and 
uterine horn with 10 mL pre-warmed Dulbecco Phosphate Buffered Saline supplemented with 
0.2% of Bovine Serum Albumin. After recovery, morphologically normal embryos (morulae 
and blastocysts) were classified as normal according to International Embryo Transfer Society 
classification and pooled to randomize embryo effect. 
 
Embryo transfer by laparoscopy 
Morphologically normal embryos (Fig. 2A) were transferred into oviducts by laparoscopy to 14 
recipient does (13 to 15 embryos per recipient) following the procedure described by 
Besenfelder and Brem [12]. Ovulation was induced in recipient does with an intramuscular dose 
of 1 mg of Buserelin Acetate 68-72 hours before transfer.  
 
To sedate the does during laparoscopy, anesthesia was administered by an intramuscular 
injection of 5 mg/Kg of xylazine, followed 5-10 min later by an intravenous injection into the 
marginal ear vein of 6 mg/Kg of ketamine hydrochloride. During laparoscopy, 3 mg/kg of 
morphine hydrochloride was administered intramuscularly. After transfer, does were treated 
with antibiotics (4mg/Kg of gentamicin every 24h for 3 days) and analgesics (0.03mg/Kg of 
buprenorphine hydrochloride every 12 hours for 3 days and 0.2mg/Kg of meloxicam every 24h 
for 3 days). 
 
Effect of embryo transfer on differential mRNA expression 
Thirteen does were euthanized at day 6 post-insemination (n=6 for manipulated embryos and 
n=7 for non-manipulated embryos) with an intravenous injection of 200 mg/Kg of pentobarbital 
sodium. Eight independent pools of 6-8 blastocysts were produced for each experimental group 
(control and transferred, Fig. 1A). RNA was extracted with Dynabeads kit (Invitrogen Life 
Technology) according to the manufacturer’s instructions and treated with DNase I to eliminate 
genomic DNA contamination. Then, reverse transcription was carried out using Reverse 
Transcriptase Quantitect kit (Qiagen). Real-time PCR reactions were conducted in an Applied 
Biosystems 7500. Every PCR was performed from 5 µL diluted 1:10 cDNA template, 250 nM 
of forward and reverse specific primers (Table 1) and 10 µL of PowerSYBR Green PCR Master 
Mix  in a final volume of 20 µL. The PCR protocol included an initial step of 50ºC (2 min), 
followed by 95ºC (10 min) and 42 cycles of 95ºC (15s) and 60ºC (30s). After real-time PCR, a 
melting curve analysis was performed by slowly increasing the temperature from 65ºC to 95ºC, 
with continuous recording of changes in fluorescent emission intensity. The amplification 
products were confirmed by SYBR Green-stained 2% agarose gel electrophoresis in 1X Bionic 
buffer. Serial dilutions of cDNA pool made from several samples were done to assess PCR 
efficiency. A ΔΔCt method adjusted for PCR efficiency was used, employing the geometric 
average of H2AFZ (H2A histone family member Z) and GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) as housekeeping normalization factor [13].  
 
Effect of embryo transfer on implantation rate, offspring rate at birth and embryonic and 
fetal losses  
 
Fourteen does (n=8 for manipulated embryos and n=6 for control group) were employed in this 
task. A total of 73 embryos were transferred for the manipulated embryos group. Implantation 
rates were assessed by laparoscopy following the previous procedure, noting the number of 
implanted embryos at day 12 from total embryos transferred and birth rate (offspring born/total 
embryos transferred) for transferred embryos and noting the number of implanted embryos at 
day 12 from total number of corpora lutea and birth rate (offspring born/total number of 
corpora lutea) for control embryos. A total of 104 corpora lutea  (presumptive embryos) were 
counted for the control group. Embryonic losses were calculated as the difference between 
embryos transferred and implanted embryos for transferred embryos and between total numbers 
of corpora lutea and implanted embryos for control embryos. Fetal losses were calculated as the 




Data on relative mRNA abundance was normalized by a Napierian logarithm transformation 
and evaluated using a generalized linear model. Implantation and offspring rates at birth and 
embryonic and fetal loss rates were also analyzed using a generalized linear model. The error 
was designated as having a binomial distribution using probit link function.  Binomial data for 
implantation rate, offspring rate at birth and fetal losses were assigned as 1 if positive 
development had been achieved or a 0 if it had not. A P value of less than 0.05 was considered 
to indicate a statistically significant difference. The data are presented as least square mean ± 
standard error mean. All statistical analyses were carried out using SPSS 21.0 software package 




The relative abundance based on the geometric average of H2AFZ and GAPDH of candidate 
gene transcripts of transcription factor octamer binding 4 (OCT4), epithelial membrane protein 
1 (EMP1), C1q tumor necrosis factor 1 (C1QTNF1), secretoglobin family 1A member 1 
(SCGB1A1), annexin A3 (ANXA3), tumor necrosis factor alpha-induced protein 6 (TNFAIP6), 
alpha hemoglobin (HBA) and fibronectin type III and laminin G domains (EGFLAM) are 
shown in Fig. 3. Significant differences were found among preimplantational embryos for 
OCT4, EMP1, C1QTNF1 and TNFAIP6 (P < 0.05, Fig. 3). OCT4, C1QTNF1 and TNFAIP6 
mRNA expression were lower in transferred embryos, while EMP1 mRNA expression was 
higher in transferred embryos (Fig. 3).  The analysis of SCGB1A1, ANXA3, HBA and 
EGFLAM showed no significant differences (Fig. 3).   
 
The rate of implantation and development to term was significantly lower in the transferred 
groups than in the control (74±5.1% vs 92±2.6% for implantation rate and 66±5.6% vs 79±4.0% 
for offspring rate at birth, for transferred and control embryos, respectively, P < 0.05, Table 2). 
Embryonic losses were significantly higher in the transferred group than in the control 
(26±5.1% vs 8±2.6%, for transferred and control embryos, respectively, P < 0.05, Table 2). 
However, fetal losses were similar between groups (9±3.9% and 15±3.6%, for transferred and 




Given the importance of embryo transfer manipulation in ART and the lack of information 
available on the molecular mechanisms that link the in vitro manipulation of gametes and 
embryos with perinatal alterations, we focused our study on the effect of embryo transfer 
manipulation on candidate gene expression during pre-implantation development and its 
consequences on implantation rate and offspring rates at birth. Two major findings originated 
from this study. First, we identified differences in the mRNA expression of pre-implantation 
blastocysts that were subjected to embryo transfer manipulation. Second, we showed that 
embryo transfer manipulation affected embryonic losses as a consequence of faulty embryonic 
implantation. 
 
Embryo recovery and transfer is a technique inherent in most ART and despite this minimal 
embryo manipulation, alterations occur at the molecular level before the implantation process 
begins. The candidate genes analyzed in this study were selected because of their role in 
implantation, placental development or gestational losses [14, 15, 16]. In particular, we 
observed that transferred embryos have a lower transcript abundance of OCT4. OCT4 is 
regarded as a key regulator of the pluripotency maintenance system [17]. The main function of 
this transcriptional factor is to activate or repress several target genes involved in many cases in 
cell differentiation and early embryonic development [18]. The altered expression of OCT4 in 
preimplantational embryo is associated with embryos of lower quality [19]. In contrast, EMP1 
was up-regulated in transferred embryos. EMP1 is thought to be involved in the regulation of 
different processes such as cell cycle or cell–cell recognition, and high levels of EMP1 
expression have been related with cell differentiation and arrest [20].  Taking into account these 
results, signals involved in cell proliferation and differentiation cell during gastrulation and 
implantation events could be disturbed.  Furthermore, C1QTNF1 and TNFAIP6 mRNA 
expression were down-regulated by transfer manipulation. Both genes are characterized by a 
common TNF alpha-like globular domain. Cytokine tumor necrosis factor α (TNF) is a well-
known member of the TNF superfamily with many different kinds of biological functions, such 
as controlling expression of cytokines, immune receptors, proteases, growth factors and cell 
cycle genes which in turn regulate inflammation, survival, apoptosis, cell migration, 
proliferation and differentiation [21]. It has been observed that aberrant levels of TNF are 
associated with diverse reproductive diseases such as spontaneous abortions, preeclampsia, 
preterm labor or endometriosis [21]. Hence, concentrations, receptor distribution and length of 
stimulation determine whether TNF has beneficial or adverse effects on pregnancy [21].  
 
Our data suggest that embryo transfer manipulation is not as neutral as expected and led to a 
detectable perturbation of gene expression. It has been demonstrated that suboptimal conditions 
during the periconception period induce gene expression and epigenetic changes in gametes and 
embryos that can be maintained during post-implantation development  [2]. In particular, 
alterations have been described at genetic and epigenetic level in placentas derived from in vitro 
fertilization, intracytoplasmic sperm injection or in vitro culture of embryos [22, 23, 24]. 
However, there was still a lack of knowledge about alterations induced by embryo transfer 
manipulation. Recently, de Waal et al. [4] reported a significant increment in placental weight in 
mouse together with an up-regulation of Tpbpa expression, a gene marker of the junctional zone 
for glycogen and spongiotrophoblast cells. In that sense, our results demonstrated that this 
perturbation of gene expression has consequences on the implantation and birth rates. In rabbits, 
as of 6th day of gestation there are two critical moments for fetal survival; the first between 
days 8 and 12 of gestation, when endometrial attachment, decidual reaction and the first steps of 
fetal and hemochorial placental development take place. The second is between days 17 and 24, 
corresponding with the period of uterine enlargement, when the hemochorial placenta has 
finished its development and the nutrition of the fetus begins to be controlled by the placenta 
[25]. In rabbit, gestational losses have been estimated at around 14% from fertilization to the 
onset of implantation (around day 7 of gestation) and 20–30% for overall gestation period [26, 
27, 28, 29]. However, in this study, we found important differences in embryonic loss rates at 
12th day of gestation in transferred embryos, observing that after transfer manipulation not all 
embryos which reach the last pre-implantatory stage (Day-6 old) had the ability to implant. Pre-
implantation embryo development, which leads to blastocyst formation, is among the most 
important events that control the establishment of pregnancy, along with endometrial receptivity 
and the mutual cross-talk between the mother and the embryo  [30]. Therefore, formation of a 
competent blastocyst is required for implantation and establishment of pregnancy [31].  Early 
embryo losses may result if there is an inherited abnormal development and the embryo stage of 
development is not synchronized with the maternal environment  [32]. Nevertheless, residual 
damage in late blastocysts (three days after transfer) seems to still be present at the molecular 
level before the implantation process begins. However, we found that embryos that have 
overcome alterations caused by transfer procedure (including embryo recovery and transfer) and 
initiate implantation would have the same ability to reach the end of pregnancy as those in the 
control group.  
 
In conclusion, the findings of the current study show that embryo transfer manipulation 
influences mRNA expression of late blastocysts prior to implantation, resulting in higher 
gestational losses as a consequence of faulty embryonic implantation. Additional research with 
new high-throughput tools will provide more information to define the factors involved in these 
embryonic losses, and to elucidate which effects they could have not only on the embryo and 
fetal physiology, but also in neonatal and adult life. 
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Figure 1. Experimental design. Embryos were recovered at day 3 of development and then 
transferred to recipient does. Some of the recipients were euthanized at day 6 in order to 
evaluate mRNA expression of 8 candidate genes. The rest of recipients were examined at day 
12 to evaluate the implantation rate and the offspring rate at the end of gestation. 
 
Figure 2. Rabbit embryos at 3 and 6 days of development. (A) Three-day-old embryos at 
100x. (B) Six-day-old blastocyst at 20x. 
 
Fig. 3. mRNA expression (mean±SEM) of ANXA3, SCGB1A1, EMP1, EGFLAM, OCT4, 
TNFAIP6, HBA and C1QTNF1 in 6-day-old blastocysts develop in vivo after transfer 
manipulation (n =8/group/type). Values from real-time PCR were normalized to geometric 
average of H2AFZ and GAPDH. AU, arbitrary units. Asterisks indicate a difference between 
groups (P < 0.05). 
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